Skip to content
2000
Volume 10, Issue 3
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Recently, δ opioid receptor agonists have been proposed to be attractive targets for the development of novel antidepressants. Several studies revealed that single treatment of δ opioid receptor agonists produce antidepressant-like effects in the forced swimming test, which is one of the most popular animal models for screening antidepressants. In addition, subchronic treatment with δ opioid receptor agonists has been shown to completely attenuate the hyperemotional responses found in olfactory bulbectomized rats. This animal model exhibits hyperemotional behavior that may mimic the anxiety, aggression, and irritability found in depressed patients, suggesting that δ opioid receptor agonists could be effective in the treatment of these symptoms in depression. On the other hand, prototype δ opioid receptor agonists produce convulsive effects, which limit their therapeutic potential and clinical development. In this review, we presented the current knowledge regarding the antidepressant-like effects of δ opioid receptor agonists, which include some recently developed drugs lacking convulsive effects.

Loading

Article metrics loading...

/content/journals/cn/10.2174/157015912803217314
2012-09-01
2025-07-08
Loading full text...

Full text loading...

/content/journals/cn/10.2174/157015912803217314
Loading

  • Article Type:
    Research Article
Keyword(s): Anxiety; depression; KNT-127; naltrindole; SNC80; TAN-67
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test